INTDOSKIT:用于计算剂量系数和研究它们的不确定性的一种R代码
Bastian Breustedt1, Niranjan Chavan2, Thomas Makumbi2
1Karlsruhe Institute of Technology, Institute of Biomedical Engineering (IBT), Fritz-Haber-Weg 1, D-76131 Karlsruhe, Germany.
Health physics
|September 16, 2024
概括
一个新的R码,INTDOSKIT,使用国际辐射保护委员会 (ICRP) 模型计算时间依赖的辐射剂量分布. 这种经过验证的工具有助于评估辐射暴露,并支持辐射保护中的不确定性分析.
科学领域:
- 辐射物理学 辐射物理学
- 计算剂量计计算剂量计.
- 辐射保护 辐射保护
背景情况:
- 准确计算辐射剂量对于辐射保护至关重要.
- 现有的模型需要强大的计算工具来实现实际应用.
- 国际辐射保护委员会 (ICRP) 为剂量评估提供了参考模型.
研究的目的:
- 根据ICRP参考模型开发一个R-code (INTDOSKIT) 来计算依赖时间的活性分布和剂量.
- 通过与已建立的数据集和软件对开发的代码进行验证.
- 为了证明代码在处理不确定性和敏感性分析方面的能力.
主要方法:
- 开发了一组R函数和常数 (INTDOSKIT).
- 实施ICRP关于活动分布和衰变的参考模型.
- 使用ICRP OIR数据查看器和已发表的衰变链模型 (例如233Ra) 的数据进行验证.
- 通过试点研究测试不确定性和灵敏度分析能力 (241Am注射).
主要成果:
- INTDOSKIT代码成功计算了依赖时间的活性分布和剂量.
- 与参考数据的验证显示了最小的偏差 (几百分比),归因于圆.
- 该代码准确地复制了ICRP生物测试数据和剂量系数.
- 对241Am注射的不确定性分析给出了与文献相一致的剂量系数的GSD.
结论:
- INTDOSKIT为辐射保护中剂量评估提供了可靠和经过验证的工具.
- R-code促进了ICRP模型的应用,并支持高级分析.
- 开发的工具适用于计算辐射剂量,执行不确定性和灵敏度研究.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Dose-Response Relationship: Overview
3.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.1K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
423
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
423
Calculating and Interpreting the Linear Correlation Coefficient
5.9K
The correlation coefficient, r, developed by Karl Pearson in the early 1900s, is numerical and provides a measure of strength and direction of the linear association between the independent variable, x, and the dependent variable, y. Hence, it is also known as the Pearson product-moment correlation coefficient. It can be calculated using the following equation:
5.9K
Statistical Methods for Analyzing Epidemiological Data
324
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
324
Dose-Response Relationship: Potency and Efficacy
4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K


